Further studies found that circRIP2 can increase Tgf-β2 levels in bladder cancer tissues by sponging miR-1305 and inducing tumor progression and epithelial–mesenchymal transition through the Tgf-β2/smad3 pathway (Su et al., 2020). Here, TGFB2 is linked to urinary bladder cancer.